Check Cap is a diagnostics & research business based in the US. Check Cap shares (CHEK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.42 – a decrease of 2.07% over the previous week.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.42 |
|---|---|
| 52-week range | $1.13 - $3.94 |
| 50-day moving average | $1.71 |
| 200-day moving average | $2.05 |
| Wall St. target price | $7.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-3.00 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.42 from 2024-10-15
| 1 week (2024-10-09) | -0.91% |
|---|---|
| 1 month (2024-09-16) | -21.98% |
| 3 months (2024-07-16) | -29.88% |
| 6 months (2024-04-16) | -36.04% |
| 1 year (2023-10-16) | -57.23% |
|---|---|
| 2 years (2022-10-12) | N/A |
| 3 years (2021-10-15) | 70.06% |
| 5 years (2019-10-16) | 1.9786 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -31.69% |
| Return on equity TTM | -54.06% |
| Profit margin | 0% |
| Book value | $4.05 |
| Market Capitalization | $8.3 million |
TTM: trailing 12 months
We're not expecting Check Cap to pay a dividend over the next 12 months.
Check Cap's shares were split on a 1:20 basis on 24 November 2022. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Check Cap shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Check Cap shares which in turn could have impacted Check Cap's share price.
Over the last 12 months, Check Cap's shares have ranged in value from as little as $1.13 up to $3.937. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Check Cap's is 0.159. This would suggest that Check Cap's shares are less volatile than average (for this exchange).
Check-Cap Ltd. , a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel. .
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.